A media-savvy caregiver brings Alzheimer’s patients to the table in drug research

Meryl Comer sat on stage at the BIO International Convention in San Diego last month between two prominent scientists: Francis S. Collins, director of the National Institutes of Health, and Jan M. Lundberg, head of R&D at Eli Lilly & Co. The three were on hand to discuss the Accelerating Medicines Partnership, or AMP, a new public-private drug discovery consortium. A former television news reporter who now heads the Geoffrey Beene Foundation Alzheimer’s Initiative, Comer leveraged her mastery of visual communication to solidly upstage her copanelists.

Read full article.